A research team at the University of California, Riverside (UC Riverside) in the US has evaluated a new device manufactured by tissue sampling devices maker Histologics.
US-based Sciex Diagnostics has launched a new fully integrated LC-MS solution, Sciex Topaz System, for use in clinical diagnostics.
US-based life sciences firm Emergent BioSolutions has secured around $23m for the development of a new multi-drug auto-injector to deliver nerve agent antidote.
US-based medical devices maker Qfix has introduced its new ZiFix Abdominal/Thoracic Motion Control System designed to stimulate shallow breathing for the management of internal body motion caused due to respiration.
Cardinal Health has concluded the purchase of Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business from Medtronic for a total of $6.1bn.
Patients with hepatitis C in Europe could soon gain access to two new pan-genotypic treatment options after the European Commission issued approval for AbbVie’s Maviret and Gilead’s Vosevi following an accelerated review.
Medication management systems provider Plexus Technology Group (TG) is set to integrate its anaesthesia information management system (AIMS) with medical imaging firm Codonics’ medication safety technology Safe Label System (SLS) for an improved anaesthesia process.
AstraZeneca and Merck & Co have announced a global strategic oncology collaboration to co-develop and co-commercialise the former’s Lynparza and selumetinib for multiple cancer types.
Novo Nordisk’s diabetes drug Victoza is now approved in Europe as the only GLP-1 analogue with a label including prevention of cardiovascular events.
Medtronic’s Canadian subsidiary has launched its new magnetic resonance imaging (MRI) conditional cardiac resynchronisation therapy defibrillators (CRT-Ds)
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.